Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06930638 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MitoQ and Ischemic Conditioning To Assess Vascular Health Outcomes

Study acronym: MITO
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Phase: Early Phase 1 to Phase 2 Trial status: Not Yet Recruiting to Recruiting · Study sites: 0 to 1 · Start date changed from estimate of Jun 1, 2025 to Jul 22, 2025v2 Show 3 more changesShow less
    • Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 1, 2025 to Jul 22, 2025
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Stroke survivors have compromised vascular function which may contribute to secondary stroke risk, cardiovascular disease, and may limit their exercise tolerance. Preliminary data shows a single bout of ischemic conditioning or oral ingestion of an over-the-counter antioxidant supplement called MitoQ may improve vascular function and muscle activity in individuals post-stroke.
Trial Details
NCT Number NCT06930638
Lead Sponsor Medical College of Wisconsin
Conditions Stroke
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov